JP2014503829A5 - - Google Patents

Download PDF

Info

Publication number
JP2014503829A5
JP2014503829A5 JP2013551330A JP2013551330A JP2014503829A5 JP 2014503829 A5 JP2014503829 A5 JP 2014503829A5 JP 2013551330 A JP2013551330 A JP 2013551330A JP 2013551330 A JP2013551330 A JP 2013551330A JP 2014503829 A5 JP2014503829 A5 JP 2014503829A5
Authority
JP
Japan
Prior art keywords
macromolecule
igm
resulting
immune system
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013551330A
Other languages
English (en)
Japanese (ja)
Other versions
JP6068362B2 (ja
JP2014503829A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/022706 external-priority patent/WO2012103324A2/en
Publication of JP2014503829A publication Critical patent/JP2014503829A/ja
Publication of JP2014503829A5 publication Critical patent/JP2014503829A5/ja
Application granted granted Critical
Publication of JP6068362B2 publication Critical patent/JP6068362B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013551330A 2011-01-28 2012-01-26 腸および血液脳関門の透過性を検出する方法、およびその試験材料 Active JP6068362B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161437244P 2011-01-28 2011-01-28
US61/437,244 2011-01-28
PCT/US2012/022706 WO2012103324A2 (en) 2011-01-28 2012-01-26 Method for detection of intestinal, and blood-brain barrier permeability and testing materials thereto

Publications (3)

Publication Number Publication Date
JP2014503829A JP2014503829A (ja) 2014-02-13
JP2014503829A5 true JP2014503829A5 (enExample) 2016-02-04
JP6068362B2 JP6068362B2 (ja) 2017-01-25

Family

ID=46577669

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013551330A Active JP6068362B2 (ja) 2011-01-28 2012-01-26 腸および血液脳関門の透過性を検出する方法、およびその試験材料

Country Status (12)

Country Link
US (2) US8663911B2 (enExample)
EP (1) EP2668498B1 (enExample)
JP (1) JP6068362B2 (enExample)
KR (1) KR101941308B1 (enExample)
CN (2) CN105823887B (enExample)
AU (3) AU2012211328A1 (enExample)
BR (1) BR112013019380A2 (enExample)
CA (2) CA2964555C (enExample)
IL (2) IL227676A (enExample)
MX (1) MX2013008746A (enExample)
RU (2) RU2016149216A (enExample)
WO (1) WO2012103324A2 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2628013B1 (en) 2010-10-14 2019-06-12 The Johns Hopkins University Biomarkers of brain injury
US9709573B2 (en) 2012-03-13 2017-07-18 The Johns Hopkins University Citrullinated brain and neurological proteins as biomarkers of brain injury or neurodegeneration
US20140147856A1 (en) * 2012-11-29 2014-05-29 Rush University Medical Center Intestinal Permeability Assay for Neurodegenerative Diseases
WO2015009907A1 (en) 2013-07-17 2015-01-22 The Johns Hopkins University A multi-protein biomarker assay for brain injury detection and outcome
CN107533048A (zh) 2015-02-05 2018-01-02 美国免疫阵列公司 用于诊断脑损伤或神经退行性变的方法和组合物
US11131676B2 (en) 2016-02-25 2021-09-28 The Trustees Of Columbia University In The City Of New York Systemic immune activation and biomarkers of nonceliac wheat/gluten sensitivity
CN105974105A (zh) * 2016-05-16 2016-09-28 河北艾驰生物科技有限公司 基质金属蛋白酶-3(mmp3)检测试剂盒
JP6782886B2 (ja) 2017-01-19 2020-11-11 国立大学法人島根大学 腸粘膜の透過性の診断薬、診断方法、診断装置
CN108191977B (zh) * 2017-12-25 2018-12-18 首都医科大学宣武医院 用于检测缺血性脑卒中血脑屏障早期损伤的抗体及其应用
CN108152492B (zh) * 2017-12-25 2019-03-08 首都医科大学宣武医院 用于检测缺血性脑卒中血脑屏障早期损伤的抗体及其应用
US12262983B2 (en) 2018-02-07 2025-04-01 University Of Cincinnati System and method for detecting small blood-tissue barrier disruption
KR102341906B1 (ko) * 2018-10-26 2021-12-22 가천대학교 산학협력단 청년기 우울증 동물모델의 제조방법
CN112958172B (zh) * 2021-02-24 2021-12-28 北京航空航天大学 一种模拟体内微生物-肠-脑轴信号传导过程的仿生微流控芯片

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020028215A1 (en) * 1999-08-09 2002-03-07 Jagath L. Kadurugamuwa Novel vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, and methods for preparing same
DE19842609C2 (de) * 1998-09-17 2000-09-21 Diagnostik Gmbh Leipzig Lab Salmonellenantigengemisch und Kit zur Bestimmung von Antikörpern gegen Salmonellen
US6958324B2 (en) * 1998-12-02 2005-10-25 Inotek Pharmaceuticals Corporation Inosine compounds and their use for treating or preventing an inflamation or a reperfusion disease
US6884591B2 (en) * 2001-06-25 2005-04-26 The Cleveland Clinic Foundation Peripheral marker of blood brain barrier permeability
CN1788017B (zh) * 2003-02-10 2013-04-24 to-BBB控股股份有限公司 炎症状态下在血脑屏障中差异表达的核酸
US20080038843A1 (en) * 2006-08-11 2008-02-14 University Of Maryland - Baltimore Method of diagnosing celiac disease
CA2651366A1 (en) * 2005-05-13 2006-11-23 Alessio Fasano Method for assessing the effectiveness of a treatment regimen
US7795314B2 (en) * 2005-06-01 2010-09-14 Cytokine Pharmasciences, Inc. Protective role of semapimod in necrotizing enterocolitis
EP1757940A1 (en) * 2005-08-26 2007-02-28 Cézanne S.A.S. In vitro method for diagnosing and monitoring renal cell carcinoma (RCC) using MMP-7 as humoral biomarker for RCC
JP4791866B2 (ja) * 2006-03-24 2011-10-12 国立大学法人秋田大学 下痢原性大腸菌感染症の判別に用いられる固相等
US7892763B2 (en) * 2009-01-26 2011-02-22 Dodds W Jean Multi-stage nutrigenomic diagnostic food sensitivity testing in animals

Similar Documents

Publication Publication Date Title
JP2014503829A5 (enExample)
PH12021550083A1 (en) Human anti-tau antibodies
WO2017123636A8 (en) Dosage and administration of anti-c5 antibodies for treatment
IL291613A (en) Inhibitory anti-factor xii/fxiia monoclonal antibodies, method of producing the same, pharmaceutical composition containing the same and medical uses
EA201291243A1 (ru) Антитела против респираторно-синцитиального вируса (рсв) и способы их применения
BR112018076767A2 (pt) anticorpos de ligação a cd3
WO2017132562A8 (en) Antigen binding proteins that bind pd-l1
JO3744B1 (ar) مواد ربط لـpd1 و/ أو lag3
MX356947B (es) Anticuerpos bioespecíficos específicos para antígenos que activan células t y un antígeno tumoral y métodos de uso.
WO2013043933A3 (en) Cd27l antigen binding proteins
CA3204788C (en) Antibodies comprising an antigen-binding site that specifically binds to two different epitopes and methods of making them
DK2681244T3 (da) Cea-antistoffer
WO2017004026A8 (en) Anti-cd123 antibodies and conjugates and derivatives thereof
BR112014000263A2 (pt) anticorpo isolado ou fragmento de ligação de antígeno do mesmo, molécula de ácido nucleico, e, composição farmacêutica
HK1212711A1 (zh) Bcma抗原結合蛋白
CN110337449A (zh) 抗pd-l1抗体及其应用
MA53750A (fr) Anticorps anti-bcma, molécules de liaison d'antigène bispécifiques qui se lient au bcma et cd3 et leurs utilisations
CN103562403A8 (zh) 识别肿瘤起始细胞的抗体和抗原及其应用
WO2010010466A3 (en) Neutralizing anti-influenza a virus antibodies and uses thereof
WO2013192550A3 (en) Anti-jagged 1/jagged 2 cross-reactive antibodies, activatable anti-jagged antibodies and methods of use thereof
WO2013061163A3 (en) Tdp-43 specific binding molecules
WO2013051878A3 (en) Antibody specifically binding to epitope in sema domain of c-met
EP1930025A4 (en) ANTIGEN-AND-DRUG VEHICLE WHICH ENABLES THE CHANGEOVER FROM THE SELECTIVE PRODUCTION OF IgA ANTIBODY TO THE PRODUCTION OF BOTH OF IgA AND IgG ANTIBODIES, AND TRANSNASAL/TRANSMUCOSAL VACCINE USING THE VEHICLE
EP2949675A4 (en) HUMANIZED ANTI-HMGB1 ANTIBODIES OR ANTIGEN-BINDING FRAGMENT THEREOF
JP2013538186A5 (enExample)